Article Details

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Consensus Rating of “Buy” by Analysts

Retrieved on: 2022-06-10 19:09:19

Tags for this article:

Click the tags to see associated articles and topics

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Consensus Rating of “Buy” by Analysts. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 2,699,490 shares of the company's stock worth $111,730,000 after purchasing an additional 13,868 shares in the last ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up